GOSS
GOSS
US38341P1021
Gossamer Bio, Inc.
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 35/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 2.2x as much as the broader market.

Beta (Market Relation)
2.21x
Above average
Volatility (5Y p.a.)
107.8% p.a.
5-Year Horizon
Max Drawdown (5Y)
-99.2%
5-Year Horizon
Sharpe Ratio
-0.58
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Stable Long-Term Volatility High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -94.9%
3 Years 109.8% -96.7% -0.41 -42.4%
5 Years 107.8% -99.2% -0.58 -60.3%
10 Years — — — —

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
High market risk: Beta of 2.21 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (107.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -99.2% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)
Overall Governance Risk
7 ISS Score: 7 / 10
Audit Risk
7 ISS Score: 7 / 10
Board Risk
8 ISS Score: 8 / 10
Short Ratio
3.28
ende